[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6147 followers
Created: 2025-07-22 08:28:51 UTC

Blue Jet Healthcare Q1 FY26: Strong YoY Growth, But Margins Dip 📊 | MCap XXXXXXXXX Cr

- Q1 FY26 revenue: ₹3,548M (+117.8% YoY, +4.2% QoQ)
- EBITDA: ₹1,210M (+173.3% YoY), margin at XXXX% (+693 bps YoY)
- PAT: ₹912M (+141.3% YoY), margin at XXXX% (+251 bps YoY)
- QoQ declines: EBITDA -13.6%, PAT -XXXX%
- Gross margin drop: XXXX% (Q1) vs XXXX% (Q4) due to product mix & inventory
- Growth drivers: Higher PI & API sales
- Strategic focus: Operational efficiency, capacity expansion, R&D
- Key clients: GE Healthcare, Guerbet, Bracco, Colgate Palmolive, Unilever
- Business model: Specialty pharma/healthcare ingredients (CDMO)

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

![](https://pbs.twimg.com/media/GwcsnuFbIAACjhf.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947574551111761975/c:line.svg)

**Related Topics**
[mcap](/topic/mcap)
[dip](/topic/dip)
[coins healthcare](/topic/coins-healthcare)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1947574551111761975)